|
J.
Cancer Mol. 2: 73-77, 2006
[Research Paper]
Expression of Heat Shock Proteins HSP10, HSP27, HSP60, HSP70, and
HSP90 in Urothelial Carcinoma of Urinary Bladder
Francesco Cappello, Sabrina David, Nella Ardizzone, Francesca Rappa,
Lorenzo Marasà,
Fabio Bucchieri, and Giovanni Zummo
Human Anatomy Section, Department of Experimental Medicine,
University of Palermo, Palermo, Italy [F. Cappello, S. David, N.
Ardizzone, F. Bucchieri, G. Zummo]; Division of Pathological
Anatomy, ˇ§ARNAS Civicoˇ¨ Hospital, Palermo, Italy [F. Rappa, L.
Marasà]
Abstract:
AIM:
Heat shock proteins (HSPs) have essential roles in a number of
pathophysiologic conditions including carcinogenesis and represent a
group of novel molecular markers in cancer management. The aim of
this study is to explore the expression status of HSPs in bladder
urothelial carcinoma (BUC) patients.
METHODS:
The immunohistochemical staining of HSP10, HSP27, HSP60, HSP70, and
HSP90 were done in 46 vesical BUC patients with different grades (G)
and stages (T). Statistical analyses were performed to determine
whether there was any correlation between tumoral HSP expression and
both G and T of tumors.
RESULTS:
We found a significant correlation between high grading (G ≥ 2) and
tumor tissues positive for HSP10 and HSP90 staining (P <
0.001). Moreover, the positive immunostaining of HSP70 was
significantly linked with G3 tumors (P < 0.001), but HSP27 or
HSP60 expression was not related with the G level of tumor. There
was a significant correlation between higher T stages (T > 1) and
tumor tissues expressing HSP70 (P < 0.001); in contrast, the
number of tumor cells having HSP60 expression was significantly
decreased
in T > 1 tumors (P < 0.005). No relationship was found
between tumoral T status and HSP10, HSP27 and HSP90 expression.
Finally, we found a significant correlation between the high-graded
(G ≥ 2) neoplasms and the percentage of tumoral cells positive for
HSP10, HSP27, HSP70, or HSP90 (P < 0.005).
CONCLUSION:
This is the first report to show the presence of HSP10 in bladder
cancer tissues, with its expression correlated to the tumoral
grading. These data may also be valuable for developing new
molecular anti-cancer therapies.
(Keywords:
bladder cancer; carcinogenesis; clinical
outcome; molecular markers)
Received 1/5/06;
Revised 2/15/06; Accepted 2/21/06.
1Correspondence:
Dr.
Francesco Cappello, Via alla Falconara 120, 90136 ˇV Palermo ˇV Italy.
Fax: +39-091-6553518. E-mail:
francapp@hotmail.com
2Abbreviations:
BUC,
urothelial carcinoma of bladder; T, tumor stage; G, tumor grade; HSP,
heat shock protein. |